Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Alligator Bioscience
Alligator Bioscience
Activities:
Regulatory
Research & Development
X
LinkedIn
Trending Articles
AbbVie and Gedeon Richter join forces to advance neuropsychiatric target R&D
The companies will aim to discover and progress targets for neuropsychiatric disorders
Containment in a high potent manufacturing facility
Throughout the pharmaceutical industry, there is a lack of consistency regarding the assignment of Occupational Exposure Limits (OELs) to specific bands
Rousselot
Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Aptevo and Alligator Bioscience develop immunotherapy candidate
Aptevo Therapeutics and Alligator Bioscience begin investigational new drug development to investigate the bispecific immunotherapy candidate ALG.APV-527
Ingredients
Cobra Biologics and Alligator Bioscience extend drug development partnership
Project will deliver second cell line to manufacture immuno-oncology antibody ADC-1015 following ADC-1013 success
Research & Development
J&J announces immuno-oncology collaboration with Alligator Bioscience
Alligator will complete the current Phase I study and Janssen will be responsible for all subsequent product development
Ingredients
Alligator Bioscience benefits from Cobra’s maxXpress platform
Cobra developed the cell line to express agonistic CD40 antibodies for an immuno-oncology application using its maxXpress platform
Manufacturing
Cobra to produce monoclonal antibody products for Alligator
Will provide cell line development, scale-up, GMP supplies and stability studies
Subscribe now